10/17/2012 11:19:23 AM
(LANCASTER, PA, OCTOBER 2012) Lancaster General Health is the first in Lancaster County to offer patients the Symbia® TruePoint™ SPECT•CT system from Siemens Medical Solutions, an advanced medical imaging technology that enables physicians to detect and diagnose cancer, infections of the bones and joints, and other conditions faster and more accurately.
"This new technology significantly enhances our ability to provide our patients with the highest quality health care close to home," said Thomas A. Brooks, DO, departmental director of Nuclear Imaging at LG Health. “With earlier and more precise diagnosis, our physicians can plan as well as manage treatment more effectively throughout the course of illness, which may ultimately lead to better outcomes for patients."
The SPECT•CT, installed at LG health’s Suburban Outpatient Pavilion, combines the functional imaging of single-photon emission computed tomography (SPECT) and the anatomical imaging of computed tomography (CT) into one scan. This combination of technology allows physicians at LG Health to pinpoint the exact location, size, nature, and extent of disease just about anywhere in the body. Previously, this amount of detail and accuracy would have required separate exams.
“While imaging tests like X-rays, MRIs, and traditional CT scans can show what the structures in the body look like, this new technology enables us to also obtain images of how the structures, like the internal organs, are actually working,” Dr. Brooks explained.
With the capability to perform multiple scans in a single procedure, the SPECT•CT speeds exam time and increases comfort and convenience for the patient, who undergoes a seamless procedure and only has to make one appointment. It also eliminates the potential for conflicting results due to patient movement and the time interval between separate exams.
A typical exam with the SPECT•CT takes about twenty to thirty minutes. Before the scan begins, the patient is injected with a radioactive substance or tracer, which travels in the bloodstream and targets a particular disease. During the exam, a special camera detects the tracer or “hot spot” and produces highly-defined, three-dimensional pictures of that area for a physician to review.
“This state-of-the-art technology has truly transformed our diagnostic capabilities in nuclear medicine at LGH by reshaping the way a full range of medical conditions are detected and treated,” noted Dr. Brooks.